For the month ended (dd/mm/yyyy) : | 31/08/2017 |
To : Hong Kong Exchanges and Clearing Limited
Name of Issuer | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
Date Submitted | 01/09/2017 |
Movements in Authorised Share Capital
Ordinary Shares
(1) Stock code :
02196
Description :
H Shares
No. of ordinary shares
Par value
(RMB)
Authorised share capital
(RMB)
Balance at close of preceding month
(See Remark 1)
(See Remark 1)
Increase/(decrease)
(See Remark 1)
(See Remark 1)
Balance at close of the month
(See Remark 1)
(See Remark 1)
(2) Stock code :
N/A
Description :
A Shares (Domestic Shares)
No. of ordinary shares
Par value
(RMB)
Authorised share capital
(RMB)
Balance at close of preceding month
(See Remark 1)
(See Remark 1)
Increase/(decrease)
(See Remark 1)
(See Remark 1)
(See Remark 2)
Balance at close of the month
(See Remark 1)
(See Remark 1)
Preference Shares
Stock code :
N/A
Description :
N/A
No. of preference shares
Par value
(State currency)
Authorised share capital
(State currency)
Balance at close of preceding month
Increase/(decrease)
Balance at close of the month
Other Classes of Shares
Stock code :
N/A
Description :
N/A
No. of other classes of shares
Par value
(State currency)
Authorised share capital
(State currency)
Balance at close of preceding month
Increase/(decrease)
Balance at close of the month
Total authorised share capital at the end of the month (HK$) :
(See Remark 1)
Movements in Issued Share Capital
Balance at close of preceding month
No. of ordinary shares
(1)
H Shares
(2)
A Shares
No of preference shares
No. of other classes of shares
483,940,500
2,011,190,545
N/A
N/A
Increase/ (decrease) during the month
NIL
NIL
N/A
N/A
Balance at close of the month
483,940,500
2,011,190,545
N/A
N/A
Details of Movements in Issued Share Capital
Share Options (under Share Option Schemes of the Issuer)
Particulars of share option scheme including EGM approval date (dd/mm/yyyy) and class of shares issuable | Movement during the month | No. of new shares of issuer issued during the month pursuant thereto | No. of new shares of issuer which may be issued pursuant thereto as at close of the month | |||
Granted | Exercised | Cancelled | Lapsed | |||
1. N/A | ||||||
Shares | ||||||
(Note 1) | ||||||
2. N/A | ||||||
( / / ) | ||||||
shares | ||||||
(Note 1) | ||||||
3. N/A | ||||||
( / / ) | ||||||
shares | ||||||
(Note 1) | ||||||
T | otal A. (Ordinary shares) | N/A | ||||
(Preference shares) | N/A | |||||
(Other class) | N/A | |||||
Total funds raised during the month from exercise of options (HK$) | N/A |
Warrants to Issue Shares of the Issuer which are to be Listed
nominal close value preceding | No. of new shares of issuer issued during the month pursuant thereto | No. of new shares of issuer which may be issued pursuant thereto as at close of the month | ||
Description of warrants (Date of expiry - dd/mm/yyyy) | ||||
1. N/A | ||||
( / / ) | ||||
Stock code (if listed) | ||||
Class of shares issuable (Note 1) | ||||
Subscription price | ||||
EGM approval date (if applicable) (dd/mm/yyyy) | ( / / ) | |||
2. N/A | ||||
( / / ) | ||||
Stock code (if listed) | ||||
Class of shares issuable (Note 1) | ||||
Subscription price | ||||
EGM approval date (if applicable) (dd/mm/yyyy) | ( / / ) | |||
3. N/A | ||||
( / / ) | ||||
Stock code (if listed) | ||||
Class of shares issuable (Note 1) | ||||
Subscription price | ||||
EGM approval date (if applicable) (dd/mm/yyyy) | ( / / ) | |||
4. N/A | ||||
( / / ) | ||||
Stock code (if listed) | ||||
Class of shares issuable (Note 1) | ||||
Subscription price | ||||
EGM approval date (if applicable) (dd/mm/yyyy) | ( / / ) | |||
Total B. (Ordinary shares) | N/A | |||
(Preference shares) | N/A | |||
(Other class) | N/A |
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published this content on 01 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 01 September 2017 11:07:03 UTC.
Original documenthttp://www.fosunpharma.com/uploads/201709016564.pdf
Public permalinkhttp://www.publicnow.com/view/68A31EB1BBF0F3A6041F16C8BCC905B3F5A00C7A